MRK Jan 2025 160.000 call
| Previous close | 1.0900 |
| Open | 1.0900 |
| Bid | 1.1800 |
| Ask | 1.3600 |
| Strike | 160.00 |
| Expiry date | 2025-01-17 |
| Day's range | 1.0900 - 1.0900 |
| Contract range | N/A |
| Volume | |
| Open interest | 538 |
- Yahoo Finance Video
Merck raises 2024 guidance on cancer drug demand
Shares of Merck & Company (MRK) are trading higher early Thursday after the pharmaceutical giant posted robust sales results in the first quarter, leading the pharmaceutical giant to raise its 2024 outlook. The company's performance was driven by strong demand for its cancer drug Keytruda. Yahoo Finance's Anjalee Khemlani breaks down the details. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance. This post was written by Angel Smith
- Yahoo Finance Video
Alphabet, Microsoft, Southwest earnings: What to watch
Here are some of the biggest stories investors will be watching on Thursday, April 25, 2024. A slew of companies will report their quarterly results including Microsoft (MSFT), Alphabet (GOOG, GOOGL), and Southwest Airlines (LUV). On the economic data front, the highly anticipated preliminary read on first quarter GDP will be released. Economists are expecting that the US economy grew by 2.2% in the first three months of the year. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Angel Smith
Simply Wall St.We Think Merck (NYSE:MRK) Can Stay On Top Of Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
